$176 Million is the total value of AlphaCentric Advisors LLC's 235 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 61.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| WBA | Buy | WALGREENS BOOTS ALLIANCE INC | $5,004,000 | +119.6% | 225,000 | +181.2% | 2.84% | +124.3% |
| NRZ | Buy | NEW RESIDENTIAL INVT CORP | $4,712,603 | +2.5% | 507,277 | +3.2% | 2.67% | +4.8% |
| BCRX | Buy | BIOCRYST PHARMACEUTICALS INC | $4,594,920 | +14.5% | 649,000 | +13.9% | 2.61% | +17.0% |
| HRMY | Buy | HARMONY BIOSCIENCES HLDGS IN | $3,997,940 | -3.7% | 122,000 | +3.4% | 2.27% | -1.6% |
| SHY | Buy | ISHARES TR1-3 yr tr bd etf | $3,659,034 | +68.4% | 45,190 | +68.7% | 2.08% | +72.2% |
| GLPG | Buy | GALAPAGOS NVspon adr | $3,627,750 | -9.9% | 105,000 | +6.1% | 2.06% | -7.9% |
| PCRX | Buy | PACIRA BIOSCIENCES INC | $3,160,040 | +39.6% | 103,000 | +82.3% | 1.79% | +42.7% |
| Buy | EMBECTA CORP | $3,115,350 | +54.3% | 207,000 | +121.4% | 1.77% | +57.6% | |
| Buy | TWO HARBORS INVENTMENT CORPOnote | $2,964,625 | +50.2% | 3,205,000 | +45.4% | 1.68% | +53.5% | |
| IRWD | Buy | IRONWOOD PHARMACEUTICALS INC | $2,816,775 | +68.1% | 292,500 | +85.7% | 1.60% | +71.7% |
| Buy | AMYLYX PHARMACEUTICALS INC | $2,664,105 | +14.4% | 145,500 | +34.7% | 1.51% | +16.9% | |
| QURE | Buy | UNIQURE NV | $2,626,965 | +382.6% | 391,500 | +724.2% | 1.49% | +393.4% |
| Buy | 2SEVENTY BIO INC | $2,577,400 | +41.5% | 657,500 | +265.3% | 1.46% | +44.6% | |
| CRNX | Buy | CRINETICS PHARMACEUTICALS IN | $2,438,680 | +187.9% | 82,000 | +74.5% | 1.38% | +194.3% |
| URGN | Buy | UROGEN PHARMA LTD | $2,311,650 | +46.5% | 165,000 | +8.2% | 1.31% | +49.7% |
| RVNC | New | REVANCE THERAPEUTICS INC | $2,179,300 | – | 190,000 | +100.0% | 1.24% | – |
| DX | Buy | DYNEX CAP INC | $2,167,014 | +12.1% | 181,492 | +18.2% | 1.23% | +14.6% |
| Buy | MFA FINL INC | $1,948,187 | -7.7% | 202,725 | +8.0% | 1.10% | -5.6% | |
| Buy | NEW YORK MTG TR INC | $1,706,176 | -7.5% | 200,963 | +8.1% | 0.97% | -5.5% | |
| DCPH | Buy | DECIPHERA PHARMACEUTICALS IN | $1,679,040 | +53.9% | 132,000 | +70.3% | 0.95% | +57.4% |
| PHAT | Buy | PHATHOM PHARMACEUTICALS INC | $1,659,200 | -10.9% | 160,000 | +23.1% | 0.94% | -8.9% |
| KPTI | Buy | KARYOPHARM THERAPEUTICS INC | $1,507,500 | +4.0% | 1,125,000 | +38.9% | 0.86% | +6.2% |
| IMVT | New | IMMUNOVANT INC | $1,458,820 | – | 38,000 | +100.0% | 0.83% | – |
| ARGX | Buy | ARGENX SEsponsored adr | $1,351,983 | +54.2% | 2,750 | +22.2% | 0.77% | +57.5% |
| ELS | Buy | EQUITY LIFESTYLE PPTYS INC | $1,313,127 | +142.0% | 20,611 | +154.1% | 0.74% | +147.5% |
| VRDN | Buy | VIRIDIAN THERAPEUTICS INC | $1,227,200 | +45.3% | 80,000 | +125.4% | 0.70% | +48.4% |
| ALKS | Buy | ALKERMES PLC | $1,190,425 | +8.7% | 42,500 | +21.4% | 0.68% | +11.0% |
| BCYC | New | BICYCLE THERAPEUTICS PLCsponsored ads | $1,175,265 | – | 58,500 | +100.0% | 0.67% | – |
| Buy | AG MTG INVT TR INC | $1,159,278 | +80.7% | 208,879 | +99.3% | 0.66% | +84.6% | |
| RARE | Buy | ULTRAGENYX PHARMACEUTICAL IN | $1,069,500 | -18.7% | 30,000 | +5.3% | 0.61% | -16.7% |
| IMGN | New | IMMUNOGEN INC | $991,875 | – | 62,500 | +100.0% | 0.56% | – |
| ADCT | Buy | ADC THERAPEUTICS SA | $958,416 | -42.7% | 1,068,468 | +37.3% | 0.54% | -41.4% |
| STXS | Buy | STEREOTAXIS INC | $948,000 | +12.7% | 600,000 | +9.1% | 0.54% | +15.2% |
| VRNA | Buy | VERONA PHARMA PLCsponsored adr | $912,800 | -21.5% | 56,000 | +1.8% | 0.52% | -19.7% |
| SCPH | New | SCPHARMACEUTICALS INC | $890,000 | – | 125,000 | +100.0% | 0.50% | – |
| TER | New | TERADYNE INC | $753,450 | – | 7,500 | +100.0% | 0.43% | – |
| PTGX | New | PROTAGONIST THERAPEUTICS INC | $725,580 | – | 43,500 | +100.0% | 0.41% | – |
| HLX | New | HELIX ENERGY SOLUTIONS GRP I | $670,200 | – | 60,000 | +100.0% | 0.38% | – |
| VKTX | New | VIKING THERAPEUTICS INC | $664,200 | – | 60,000 | +100.0% | 0.38% | – |
| IRTC | New | IRHYTHM TECHNOLOGIES INC | $659,820 | – | 7,000 | +100.0% | 0.37% | – |
| ZBRA | New | ZEBRA TECHNOLOGIES CORPcl a | $591,325 | – | 2,500 | +100.0% | 0.34% | – |
| NUVB | Buy | NUVATION BIO INC | $549,400 | -11.5% | 410,000 | +18.8% | 0.31% | -9.6% |
| GMED | New | GLOBUS MED INCcl a | $496,500 | – | 10,000 | +100.0% | 0.28% | – |
| New | WESTERN ASSET MORTGAGE CAPITnote 6.750% 9/1 | $481,402 | – | 500,000 | +100.0% | 0.27% | – | |
| New | REDWOOD TRUST INCnote 7.750% 6/1 | $449,688 | – | 500,000 | +100.0% | 0.26% | – | |
| New | VENTYX BIOSCIENCES INC | $416,760 | – | 12,000 | +100.0% | 0.24% | – | |
| New | ROIVANT SCIENCES LTD | $408,800 | – | 35,000 | +100.0% | 0.23% | – | |
| AKRO | New | AKERO THERAPEUTICS INC | $404,640 | – | 8,000 | +100.0% | 0.23% | – |
| DWX | Buy | SPDR INDEX SHS FDSs&p intl etf | $389,010 | -4.0% | 11,824 | +0.4% | 0.22% | -1.8% |
| REM | New | ISHARES TRmtg rel etf new | $376,340 | – | 16,846 | +100.0% | 0.21% | – |
| HYMB | Buy | SPDR SER TRnuveen bbg brcly | $309,660 | +25.1% | 13,000 | +31.3% | 0.18% | +28.5% |
| JMST | New | J P MORGAN EXCHANGE TRADED Fultra sht muncpl | $302,700 | – | 6,000 | +100.0% | 0.17% | – |
| PFF | New | ISHARES TRpfd and incm sec | $284,465 | – | 9,435 | +100.0% | 0.16% | – |
| VYM | Buy | VANGUARD WHITEHALL FDShigh div yld | $278,344 | +54.6% | 2,694 | +58.8% | 0.16% | +58.0% |
| VALN | New | VALNEVA SEsponsored ads | $242,962 | – | 20,590 | +100.0% | 0.14% | – |
| TUR | Buy | ISHARESmsci turkey etf | $145,140 | +80.7% | 3,764 | +32.4% | 0.08% | +82.2% |
| EWT | Buy | ISHARES INCmsci taiwan etf | $137,793 | -2.9% | 3,093 | +2.5% | 0.08% | -1.3% |
| KRTX | New | KARUNA THERAPEUTICS INC | $126,818 | – | 750 | +100.0% | 0.07% | – |
| EWU | Buy | ISHARES TRmsci uk etf new | $123,934 | -1.4% | 3,917 | +0.8% | 0.07% | 0.0% |
| IGSB | Buy | ISHARES TR1-3 yr cr bd etf | $84,163 | +0.8% | 1,689 | +1.4% | 0.05% | +4.3% |
| FLRN | Buy | SPDR SER TRblomberg brc inv | $85,033 | +1.1% | 2,768 | +1.0% | 0.05% | +2.1% |
| New | DOCGO INC | $39,975 | – | 7,500 | +100.0% | 0.02% | – | |
| New | PHINIA INC | $12,002 | – | 448 | +100.0% | 0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HORIZON THERAPEUTICS PUB L | 12 | Q3 2023 | 2.9% |
| INTUITIVE SURGICAL INC | 12 | Q3 2023 | 1.3% |
| STEREOTAXIS INC | 12 | Q3 2023 | 1.0% |
| ALLIED MOTION TECHNOLOGIES I | 12 | Q3 2023 | 1.3% |
| AEROVIRONMENT INC | 12 | Q3 2023 | 1.3% |
| OMNICELL COM | 12 | Q3 2023 | 0.9% |
| ACCURAY INC | 12 | Q3 2023 | 0.8% |
| COLLEGIUM PHARMACEUTICAL INC | 12 | Q3 2023 | 1.1% |
| MICROBOT MED INC | 12 | Q3 2023 | 0.5% |
| ISHARES TR | 11 | Q3 2023 | 13.1% |
View AlphaCentric Advisors LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-24 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-12 |
| 13F-HR/A | 2023-02-13 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-11-08 |
| 13F-HR | 2022-03-11 |
| 13F-HR | 2022-03-11 |
View AlphaCentric Advisors LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.